Protective Role Of Growth Hormone Secretagogues Against Myocardial Dysfunction In Mouse Models Of Myocardial Ischemia Reperfusion And Infarction
HEART(2015)
Abstract
Growth hormone secretagogues (GHS) have been shown to possess cardioprotective properties in ischaemic heart disease models. This study aimed to determine whether hexarelin, a synthetic GHS, preserves cardiac function in models of myocardial infarction (MI). MI was induced by permanent ligation of the left descending coronary artery (LAD) in C57BL/6J mice (n = 44). In a second group (n = 39), the LAD was transiently ligated, followed by reperfusion. Vehicle or hexarelin was administered at 0.3 mg/kg/day subcutaneously. Treated and sham mice were subjected to magnetic resonance imaging using a T1-weighted late gadolinium enhancement sequence (LGE) at 9.4 Tesla (T) to measure ventricular function and tissue characteristics at 24 h and 21 days post-LAD ligation. Infarct size and area-at-risk was confirmed using ex-vivo analysis at 16.4T using a 3D T1/T2*-weighted sequence using iron nanoparticles and LGE. Hexarelin-treated mice demonstrated a significant improvement (P in vivo .
MoreTranslated text
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined